Last reviewed · How we verify
Td vaccine SSI
The Td vaccine SSI induces immunity against tetanus and diphtheria.
The Td vaccine SSI induces immunity against tetanus and diphtheria. Used for Prevention of tetanus and diphtheria in individuals 7 years of age and older.
At a glance
| Generic name | Td vaccine SSI |
|---|---|
| Sponsor | Statens Serum Institut |
| Drug class | Vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
It does this by stimulating the body's immune system to produce antibodies against the toxins produced by tetanus and diphtheria bacteria. This provides long-term protection against these diseases.
Approved indications
- Prevention of tetanus and diphtheria in individuals 7 years of age and older
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |